#1
O Díaz-Cambronero, A Serrano, A Abad-Gurumeta, I Garutti Martinez, N Esteve, E Alday, C Ferrando, G Mazzinari, P Vila-Caral, C L Errando Oyonarte
We present an update of the 2020 Recommendations on neuromuscular blockade of the SEDAR. The previous ones dated 2009. A modified Delphi consensus analysis (experts, working group, and previous extensive bibliographic revision) 10 recommendations were produced1 : neuromuscular blocking agents were recommended for endotracheal intubation and to avoid faringo-laryngeal and tracheal lesions, including critical care patients.2 We recommend not to use neuromuscular blocking agents for routine insertion of supraglotic airway devices, and to use it only in cases of airway obstruction or endotracheal intubation through the device...
January 2023: Revista española de anestesiología y reanimación
#2
RANDOMIZED CONTROLLED TRIAL
Moira H D Bruintjes, Piet Krijtenburg, Chris H Martini, Paul P Poyck, Frank C H d'Ancona, Volkert A L Huurman, Michel van der Jagt, Johan F Langenhuijsen, Willemijn N Nijboer, Cornelis J H M van Laarhoven, Albert Dahan, Michiel C Warlé
BACKGROUND: Profound neuromuscular blockade (NMB) during anaesthesia has been shown to reduce postoperative pain scores, when compared with a moderate block. We hypothesised that profound NMB during laparoscopic donor nephrectomy (LDN) could also improve the early quality of recovery after surgery. OBJECTIVES: To compare the effectiveness of profound versus moderate NMB during LDN in enhancing postoperative recovery. DESIGN: A phase IV, double-blinded, randomised controlled trial...
July 2019: European Journal of Anaesthesiology
#3
RANDOMIZED CONTROLLED TRIAL
Michele Carron, Stefano Veronese, Mirto Foletto, Carlo Ori
BACKGROUND: Morbidly obese (MO) patients are at increased risk for postoperative anesthesia-related complications. We evaluated the role of sugammadex versus neostigmine in the quality of recovery from profound rocuronium-induced neuromuscular blockade (NMB) in patients with morbid obesity. METHODS: We studied 40 female MO patients who received desflurane and remifentanil anesthesia for laparoscopic removal of adjustable gastric banding. NMB was achieved with rocuronium...
October 2013: Obesity Surgery
#4
RANDOMIZED CONTROLLED TRIAL
P Van Lancker, B Dillemans, T Bogaert, J P Mulier, M De Kock, M Haspeslagh
To date, the dosing of sugammadex is based on real body weight without taking fat content into account. We compared the reversal of profound rocuronium-induced neuromuscular blockade in morbidly obese patients using doses of sugammadex based on four different weight corrections. One hundred morbidly obese patients, scheduled for laparoscopic bariatric surgery under propofol-sufentanil anaesthesia, were randomly assigned four groups: ideal body weight; ideal body weight + 20%; ideal body weight + 40%; and real body weight...
August 2011: Anaesthesia
1